<紀要論文>
癌ペプチドワクチン療法中の再燃前立腺癌患者のQOLについて

作成者
本文言語
出版者
発行日
雑誌名
開始ページ
終了ページ
出版タイプ
アクセス権
JaLC DOI
概要 The purpose of this study was to clarify QOL of hormone-refractory prostate cancer patient undergoing clinical trial. Extracted contexts from record and information which CRN collected were 1671 items.... They were categorized into 3 aspects; physical, psychological and social. As a result, we considered it as follows. 1) The degradation of QOL was not significant in 3~12 months. 2) The most unbearable distress of the patient was a physical pain. Therefore, it is important to carry out the pain control. 3) The mental support is necessary so that the patient keep having hope. 4) The support from the family is important for the patient to have his good life.続きを見る

本文情報を非表示

shsjournal2004-2_06 pdf 2.45 MB 649  

詳細

レコードID
査読有無
関連情報
主題
ISSN
NCID
タイプ
登録日 2009.04.22
更新日 2017.01.20